JPH1028724A - Fragrant deodorizing composition for feces - Google Patents
Fragrant deodorizing composition for fecesInfo
- Publication number
- JPH1028724A JPH1028724A JP8204132A JP20413296A JPH1028724A JP H1028724 A JPH1028724 A JP H1028724A JP 8204132 A JP8204132 A JP 8204132A JP 20413296 A JP20413296 A JP 20413296A JP H1028724 A JPH1028724 A JP H1028724A
- Authority
- JP
- Japan
- Prior art keywords
- scent
- glycoside
- feces
- bond
- fragrance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 210000003608 fece Anatomy 0.000 title abstract description 14
- 230000001877 deodorizing effect Effects 0.000 title abstract description 9
- 239000003205 fragrance Substances 0.000 claims abstract description 38
- 229930182470 glycoside Natural products 0.000 claims abstract description 34
- 150000002338 glycosides Chemical class 0.000 claims abstract description 34
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 235000000346 sugar Nutrition 0.000 claims abstract description 10
- 239000002781 deodorant agent Substances 0.000 claims description 15
- 239000002304 perfume Substances 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 3
- 230000002550 fecal effect Effects 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 102000038379 digestive enzymes Human genes 0.000 abstract description 8
- 108091007734 digestive enzymes Proteins 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract description 6
- 238000000354 decomposition reaction Methods 0.000 abstract description 5
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 abstract description 3
- 150000001412 amines Chemical class 0.000 abstract description 3
- 229910021529 ammonia Inorganic materials 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 16
- 230000000968 intestinal effect Effects 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 11
- 235000019645 odor Nutrition 0.000 description 10
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 8
- RMMXLHZEVYNSJO-QYSJADTOSA-N (2E)-3,7-Dimethyl-2,6-octadien-1-yl beta-D-glucopyranoside Chemical compound CC(C)=CCC\C(C)=C\CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RMMXLHZEVYNSJO-QYSJADTOSA-N 0.000 description 6
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 108010047754 beta-Glucosidase Proteins 0.000 description 6
- 102000006995 beta-Glucosidase Human genes 0.000 description 6
- RMMXLHZEVYNSJO-UHFFFAOYSA-N geranyl O-beta-D-glucopyranoside Natural products CC(C)=CCCC(C)=CCOC1OC(CO)C(O)C(O)C1O RMMXLHZEVYNSJO-UHFFFAOYSA-N 0.000 description 6
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 5
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 4
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- 102000004882 Lipase Human genes 0.000 description 4
- 108090001060 Lipase Proteins 0.000 description 4
- 239000004367 Lipase Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 4
- 229930007744 linalool Natural products 0.000 description 4
- 235000019421 lipase Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 3
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000003729 cation exchange resin Substances 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 229910001958 silver carbonate Inorganic materials 0.000 description 3
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 2
- 239000001278 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol Chemical group 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical group OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- FPCCDPXRNNVUOM-UHFFFAOYSA-N Hydroxycitronellol Chemical compound OCCC(C)CCCC(C)(C)O FPCCDPXRNNVUOM-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- BRHDDEIRQPDPMG-UHFFFAOYSA-N Linalyl oxide Chemical group CC(C)(O)C1CCC(C)(C=C)O1 BRHDDEIRQPDPMG-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical group CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- CZVXBFUKBZRMKR-UHFFFAOYSA-N lavandulol Chemical compound CC(C)=CCC(CO)C(C)=C CZVXBFUKBZRMKR-UHFFFAOYSA-N 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical group COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 229940067107 phenylethyl alcohol Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- QYNRIDLOTGRNML-UHFFFAOYSA-N primeverose Natural products OC1C(O)C(O)COC1OCC1C(O)C(O)C(O)C(O)O1 QYNRIDLOTGRNML-UHFFFAOYSA-N 0.000 description 2
- -1 rosinol Chemical compound 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229940074386 skatole Drugs 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CZVXBFUKBZRMKR-JTQLQIEISA-N (R)-lavandulol Natural products CC(C)=CC[C@@H](CO)C(C)=C CZVXBFUKBZRMKR-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- RCHLXMOXBJRGNX-UHFFFAOYSA-N 1-butylcyclohexan-1-ol Chemical group CCCCC1(O)CCCCC1 RCHLXMOXBJRGNX-UHFFFAOYSA-N 0.000 description 1
- WAPNOHKVXSQRPX-UHFFFAOYSA-N 1-phenylethanol Chemical compound CC(O)C1=CC=CC=C1 WAPNOHKVXSQRPX-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ROKSAUSPJGWCSM-UHFFFAOYSA-N 2-(7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)ethanol Chemical compound C1C2C(C)(C)C1CC=C2CCO ROKSAUSPJGWCSM-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 1
- BDCFWIDZNLCTMF-UHFFFAOYSA-N 2-phenylpropan-2-ol Chemical compound CC(C)(O)C1=CC=CC=C1 BDCFWIDZNLCTMF-UHFFFAOYSA-N 0.000 description 1
- DLHQZZUEERVIGQ-UHFFFAOYSA-N 3,7-dimethyl-3-octanol Chemical compound CCC(C)(O)CCCC(C)C DLHQZZUEERVIGQ-UHFFFAOYSA-N 0.000 description 1
- PRNCMAKCNVRZFX-UHFFFAOYSA-N 3,7-dimethyloctan-1-ol Chemical compound CC(C)CCCC(C)CCO PRNCMAKCNVRZFX-UHFFFAOYSA-N 0.000 description 1
- HMNKTRSOROOSPP-UHFFFAOYSA-N 3-Ethylphenol Chemical group CCC1=CC=CC(O)=C1 HMNKTRSOROOSPP-UHFFFAOYSA-N 0.000 description 1
- AEJRTNBCFUOSEM-UHFFFAOYSA-N 3-Methyl-1-phenyl-3-pentanol Chemical compound CCC(C)(O)CCC1=CC=CC=C1 AEJRTNBCFUOSEM-UHFFFAOYSA-N 0.000 description 1
- INIOTLARNNSXAE-UHFFFAOYSA-N 4,8-dimethyl-2-propan-2-ylidene-3,3a,4,5,6,8a-hexahydro-1h-azulen-6-ol Chemical compound CC1CC(O)C=C(C)C2CC(=C(C)C)CC12 INIOTLARNNSXAE-UHFFFAOYSA-N 0.000 description 1
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 1
- YXVSKJDFNJFXAJ-UHFFFAOYSA-N 4-cyclohexyl-2-methylbutan-2-ol Chemical compound CC(C)(O)CCC1=CC=CC=C1 YXVSKJDFNJFXAJ-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 150000008151 D-glucosides Chemical class 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000035859 Drug effect increased Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- GYCKQBWUSACYIF-UHFFFAOYSA-N Ethyl salicylate Chemical group CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- PMGCQNGBLMMXEW-UHFFFAOYSA-N Isoamyl salicylate Chemical group CC(C)CCOC(=O)C1=CC=CC=C1O PMGCQNGBLMMXEW-UHFFFAOYSA-N 0.000 description 1
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000219171 Malpighiales Species 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000006169 McIlvaine's buffer solution Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- YNMSDIQQNIRGDP-UHFFFAOYSA-N Phenethyl salicylate Chemical group OC1=CC=CC=C1C(=O)OCCC1=CC=CC=C1 YNMSDIQQNIRGDP-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- QYNRIDLOTGRNML-PNLAJEFBSA-N Vicianose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)CO1 QYNRIDLOTGRNML-PNLAJEFBSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- XPNGNIFUDRPBFJ-UHFFFAOYSA-N alpha-methylbenzylalcohol Natural products CC1=CC=CC=C1CO XPNGNIFUDRPBFJ-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940005667 ethyl salicylate Drugs 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical group O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- DUNCVNHORHNONW-UHFFFAOYSA-N myrcenol Chemical compound CC(C)(O)CCCC(=C)C=C DUNCVNHORHNONW-UHFFFAOYSA-N 0.000 description 1
- 229930008383 myrcenol Natural products 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- XOPPYWGGTZVUFP-DLWPFLMGSA-N primeverose Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O XOPPYWGGTZVUFP-DLWPFLMGSA-N 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
- QYNRIDLOTGRNML-ULAALWPKSA-N vicianose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 QYNRIDLOTGRNML-ULAALWPKSA-N 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は糞便用芳香消臭組成
物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a feces fragrance deodorant composition.
【0002】[0002]
【従来の技術】ヒト、ペット動物、家畜等の排泄物臭の
消臭のために、トイレや室内に設置または散布して芳香
を放ち、悪臭にマスキングする芳香剤や、経口摂取する
ことにより排泄物臭を消す消臭剤は、既に複数のものが
提供されている。経口摂取するタイプの消臭剤として
は、シリカゲルを配合したビスケット(特開平6−33
9344号)、悪臭物質を中和または付加反応させるマ
ッシュルームエキス(特開平5−38358号)、腸内
細菌叢を改善しかつ悪臭を持つ腐敗代謝産物の生成を減
じるとされている食物繊維単独(特開平6−21776
1号)あるいは食物繊維とタンニン酸の組み合わせ(特
開平6−256180号)等がある。2. Description of the Related Art In order to deodorize excrement odors of humans, pet animals, livestock, etc., they are installed or sprayed in toilets or indoors to emit fragrances, and to excrete by ingesting fragrances or odors by oral ingestion. A plurality of deodorants have been already provided to eliminate the odor. As a deodorant of the type to be taken orally, biscuits containing silica gel (Japanese Unexamined Patent Publication No. Hei 6-33
No. 9344), a mushroom extract for neutralizing or adding a malodorous substance (JP-A-5-38358), and dietary fiber alone which is considered to improve the intestinal flora and reduce the production of putrefactive metabolites having malodor ( JP-A-6-21776
No. 1) or a combination of dietary fiber and tannic acid (JP-A-6-256180).
【0003】[0003]
【発明が解決しようとする課題】しかし、糞便の臭い
は、主に腸内細菌による代謝産物であるアンモニア、メ
ルカプタン類、アミン類、インドール、スカトール等の
複数成分の複合臭であるため、経口摂取するタイプの上
記消臭剤では全ての便の臭い成分に対応することが困難
であり、糞便の消臭が不完全であった。また、香料を経
口摂取して糞便に芳香を付与して悪臭をマスキングさせ
ようとしても、それが消化管に達すると吸収、代謝を受
けて、その芳香を失ってしまうため糞便に香りを付与す
ることはできない。However, the odor of feces is mainly a complex odor of a plurality of components such as ammonia, mercaptans, amines, indole and skatole, which are metabolites by intestinal bacteria. With this type of deodorant, it is difficult to deal with the odor components of all feces, and the deodorization of feces was incomplete. In addition, even if a perfume is taken orally to give a scent to feces and try to mask a bad smell, when it reaches the digestive tract, it is absorbed and metabolized and loses the scent. It is not possible.
【0004】[0004]
【課題を解決するための手段】本発明者らは、かかる課
題を解決すべく鋭意研究し、消化酵素によっては分解さ
れないが、腸内細菌により分解されて香料成分を遊離
し、その香料成分が便とともに排出されるようにするこ
とにより、所期の効果をあげることができるとの知見の
もとに、糞便の不快臭の原因であるアンモニア、メルカ
プタン類、アミン類、インドール、スカトール等を産生
する腸内細菌が、β結合を有する香料配糖体を効率よく
分解して香料成分を遊離し、芳香を発生せしめることを
見い出し、本発明を完成した。このことに関しては、本
発明者らにより初めて明らかにされたものであって従来
全く報告されていない。Means for Solving the Problems The present inventors have studied diligently to solve such problems, and they are not decomposed by digestive enzymes, but are decomposed by intestinal bacteria to release fragrance components, and the fragrance components are released. Produces ammonia, mercaptans, amines, indole, skatole, etc., which are the causes of unpleasant odor in feces, based on the knowledge that the expected effect can be achieved by excreting with feces The present inventor has found that intestinal bacteria that efficiently decompose a fragrance glycoside having a β bond to release a fragrance component and generate an aroma, thereby completing the present invention. This was first clarified by the present inventors and has not been reported at all.
【0005】すなわち、本発明は、香料化合物をβ結合
を有する香料配糖体とした化合物を有効成分として含有
する糞便用芳香消臭組成物に係るものである。香料配糖
体の糞便用芳香消臭組成物に対する配合濃度は、香料配
糖体を構成している香料成分の閾値によって変化し、一
概には規定できないが、香料配糖体濃度として約0.0
1〜約30重量%の範囲にあることが、嗜好性および芳
香消臭作用の観点から好ましい。香料化合物は水酸基を
有するものであることが好ましく、また、香料配糖体と
しては、消化酵素により分解されがたいβ結合を有し、
腸内細菌により分解されて香料成分を遊離するものであ
れば全て使用可能である。That is, the present invention relates to a feces fragrance deodorant composition containing, as an active ingredient, a compound obtained by converting a fragrance compound into a fragrance glycoside having a β bond. The concentration of the fragrance glycoside in the stool aroma deodorant composition varies depending on the threshold value of the fragrance component constituting the fragrance glycoside, and cannot be specified unconditionally. 0
The content in the range of 1 to about 30% by weight is preferable from the viewpoint of palatability and aroma deodorizing action. The fragrance compound is preferably one having a hydroxyl group, and as a fragrance glycoside, has a β bond that is difficult to be decomposed by digestive enzymes,
Any substance can be used as long as it is decomposed by intestinal bacteria and releases a fragrance component.
【0006】具体的には、香料化合物に相当するアグリ
コンとしては、シス−3−ヘキセノール、リナロール、
ゲラニオール、ネロール、シトロネロール、ロジノー
ル、ジメチルオクタノール、ヒドロキシシトロネロー
ル、テトラヒドロリナロール、ラバンジュロール、ミル
セノール、α−テルピネオール、l−メントール、ボル
ネオール、ジメチルフェニルカルビノール、β−フェニ
ルエチルジメチルカルビノール、β−フェニルエチルメ
チルエチルカルビノール、フェノキシエチルアルコー
ル、フェニルグリコール、第3級ブチルシクロヘキサノ
ール、ヒドロキシシトロネラール、サリチル酸メチル、
サリチル酸エチル、サリチル酸イソブチル、サリチル酸
イソアミル、サリチル酸ベンジル、サリチル酸フェニル
エチル、リナロールオキシド、バニリン、エチルバニリ
ン、リラール、マルトール、チモール、カルバクロー
ル、オイゲノール、イソオイゲノール、イソプレゴー
ル、ノポール、ファルネソール、ネロリドール、サンタ
クロール、セドロール、ベチベロール、ベンジルアルコ
ール、2−フェニルエチルアルコール、γ−フェニルプ
ロピルアルコール、シンナミックアルコール、アニスア
ルコール、ジメチルベンジルカルビノール、メチルフェ
ニルカルビノールなどが挙げられる。[0006] Specifically, aglycones corresponding to flavor compounds include cis-3-hexenol, linalool,
Geraniol, nerol, citronellol, rosinol, dimethyloctanol, hydroxycitronellol, tetrahydrolinalool, lavandulol, myrcenol, α-terpineol, l-menthol, borneol, dimethylphenylcarbinol, β-phenylethyldimethylcarbinol, β-phenylethyl Methyl ethyl carbinol, phenoxyethyl alcohol, phenyl glycol, tertiary butyl cyclohexanol, hydroxycitronellal, methyl salicylate,
Ethyl salicylate, isobutyl salicylate, isoamyl salicylate, benzyl salicylate, phenylethyl salicylate, linalool oxide, vanillin, ethyl vanillin, linal, maltol, thymol, carvacrol, eugenol, isoeugenol, isopulegol, nopol, farnesol, nerolidol, santachlor, Examples include cedrol, vetiverol, benzyl alcohol, 2-phenylethyl alcohol, γ-phenylpropyl alcohol, cinnamic alcohol, anis alcohol, dimethylbenzylcarbinol, and methylphenylcarbinol.
【0007】糖部分としては、単糖類(グルコース、ガ
ラクトース、マンノース、グルコサミン、ガラクトサミ
ン、ラムノース、キシロース、リボース、アラビノース
等)、二糖類(シュークロース、ラクトース、マルトー
ス、ゲンチビオース、セロビオース、イソマルトース、
プリメベロース、ビシアノース、ルチノース等)が挙げ
られる。Examples of the sugar moiety include monosaccharides (glucose, galactose, mannose, glucosamine, galactosamine, rhamnose, xylose, ribose, arabinose, etc.) and disaccharides (sucrose, lactose, maltose, gentibiose, cellobiose, isomaltose,
Primeverose, Vicianose, Rutinose, etc.).
【0008】香料化合物と糖の結合は消化酵素に分解さ
れがたく、腸内細菌により分解されやすいβ結合であ
る。香料配糖体は、市販されているものがあり入手する
ことが容易であるが、公知の方法で合成することもでき
る。なお、天然原料から香料配糖体を含有する抽出物を
得ることもできる。[0008] The bond between the fragrance compound and the sugar is a β bond which is not easily decomposed by digestive enzymes and is easily decomposed by intestinal bacteria. The flavor glycosides are commercially available and are easily available, but can also be synthesized by a known method. In addition, an extract containing a fragrance glycoside can also be obtained from natural raw materials.
【0009】本発明の糞便用芳香消臭組成物は、上記の
香料配糖体の1種以上を配合して製造することができ、
そのアグリコン部分に相当する香料化合物に基づく芳香
を発する各種の組成物を包含する。具体的には、清涼飲
料、菓子、冷菓、乳製品、酒類、肉類、消臭食品等の食
品、生菌剤、胃腸薬など各種形態の医薬品、ペットフー
ド、家畜用飼料等を挙げることができる。The stool deodorant composition of the present invention can be produced by blending at least one of the above-mentioned fragrance glycosides.
Includes various compositions that emit an aroma based on the perfume compound corresponding to the aglycone moiety. Specific examples include soft drinks, confectionery, frozen desserts, dairy products, alcoholic beverages, meats, foods such as deodorant foods, probiotic agents, various forms of pharmaceuticals such as gastrointestinal drugs, pet foods, livestock feeds, and the like. .
【0010】次に、香料配糖体の合成例と酵素による分
解試験の結果について示す。Next, an example of synthesis of a fragrance glycoside and the results of a decomposition test with an enzyme will be described.
【0011】ゲラニル−β−D−グルコシドの合成 油化学、43巻、31〜38ぺージ(1994)に開示
された方法に従って、ゲラニオール2.39gとテトラ
アセチル−α−D−グルコースブロマイド4.11gを
エーテルに溶解し、シリカゲル担持炭酸銀7.1g、モ
レキュラーシーブ4A5gを加え、40℃で反応させ
た。エーテルを溜去後、ナトリウムメトキシドで加水分
解し、さらに陽イオン交換樹脂で中和した後、反応物を
シリカゲルカラムクロマトグラフィーにより精製し、ゲ
ラニル−β−D−グルコシド1.49gを得た。(収率
47%)Synthesis of Geranyl-β-D-glucoside 2.39 g of geraniol and 4.11 g of tetraacetyl-α-D-glucose bromide according to the method disclosed in Oil Chemistry, Vol. 43, 31-38 (1994). Was dissolved in ether, 7.1 g of silver carbonate supported on silica gel, and 5 g of molecular sieve 4A were added and reacted at 40 ° C. After distilling off ether, the mixture was hydrolyzed with sodium methoxide and further neutralized with a cation exchange resin, and then the reaction product was purified by silica gel column chromatography to obtain 1.49 g of geranyl-β-D-glucoside. (Yield 47%)
【0012】ゲラニル−β−D−グルコシドの核磁気共
鳴スペクトル(CD3 OD)δ(ppm):1.60
(3H,s)、1.68(6H,s)、2.08(4
H,m)、3.17(4H,m)、3.63〜3.89
(2H,dd)、4.20〜4.37(2H,m)、
4.28(1H,d,J=7.7Hz)、5.10(1
H,t)、5.36(1H,t)Nuclear magnetic resonance spectrum (CD 3 OD) δ (ppm) of geranyl-β-D-glucoside: 1.60
(3H, s), 1.68 (6H, s), 2.08 (4
H, m), 3.17 (4H, m), 3.63-3.89
(2H, dd), 4.20 to 4.37 (2H, m),
4.28 (1H, d, J = 7.7 Hz), 5.10 (1
H, t), 5.36 (1H, t)
【0013】2−フェニルエチル−β−D−グルコシド
の合成 油化学、44巻、23〜29ぺージ(1995)に開示
された方法のマルトールの糖誘導体合成法を一部改変し
て、2−フェニルエチルアルコール20.0gとセロビ
オース14.0gを1lのMcIlvaine 緩衝液(pH4.
5)に溶解し、10.0gのセルラーゼアマノTを加え
て反応させた。この反応液を、XAD−2ゲルを用いた
クロマトグラフィーでメタノール溶出により精製し、2
−フェニルエチル−β−D−グルコシド1.21gを得
た。(収率7%)Synthesis of 2-phenylethyl-β-D-glucoside A method for synthesizing sugar derivatives of maltol in the method disclosed in Oil Chemistry, Vol. 44, pp. 23-29 (1995) was partially modified to give 2-phenylethyl-β-D-glucoside. 20.0 g of phenylethyl alcohol and 14.0 g of cellobiose were added to 1 liter of McIlvaine buffer (pH 4.0).
5) and 10.0 g of Cellulase Amano-T was added and reacted. The reaction solution was purified by chromatography on XAD-2 gel by elution with methanol,
1.21 g of -phenylethyl-β-D-glucoside was obtained. (Yield 7%)
【0014】シス−3−ヘキセニル−β−D−グルコシ
ドの合成 油化学、43巻、31〜38ページ(1994)に開示
された方法に従って、シス−3−ヘキセノール1.58
gとテトラアセチル−α−D−グルコースブロマイド
4.11gをエーテルに溶解し、シリカゲル担持炭酸銀
7.1g、モレキュラーシーブ4A5gを加え、40℃
で反応させた。エーテルを溜去後、ナトリウムメトキシ
ドで加水分解し、さらに陽イオン交換樹脂で中和した
後、反応物をシリカゲルカラムクロマトグラフィーによ
り精製し、シス−3−へキセニル−β−D−グルコシド
1.05gを得た。(収率40%)Synthesis of cis-3-hexenyl-β-D-glucoside According to the method disclosed in Oil Chemistry, Vol. 43, pp. 31-38 (1994), cis-3-hexenol 1.58 was prepared.
g of tetraacetyl-α-D-glucose bromide was dissolved in ether, and 7.1 g of silver carbonate supported on silica gel and 5 g of molecular sieve 4A were added.
Was reacted. After distilling off the ether, hydrolyzing with sodium methoxide and neutralizing with a cation exchange resin, the reaction product was purified by silica gel column chromatography to obtain cis-3-hexenyl-β-D-glucoside. 05 g were obtained. (40% yield)
【0015】リナロールオキシド−β−D−グルコシド
の合成 油化学、43巻、31〜38ページ(1994)に開示
された方法に従って、リナロールオキシド2.64gと
テトラアセチル−α−D−グルコースブロマイド4.1
1gをエーテルに溶解し、シリカゲル担持炭酸銀7.1
g、モレキュラーシーブ4A5gを加え、40℃で反応
させた。エーテルを溜去後、ナトリウムメトキシドで加
水分解し、さらに陽イオン交換樹脂で中和した後、反応
物をシリカゲルカラムクロマトグラフィーにより精製
し、リナロールオキシド−β−D−グルコシド0.51
gを得た。(収率15%)Synthesis of linalool oxide-β-D-glucoside 2.64 g of linalool oxide and tetraacetyl-α-D-glucose bromide according to the method disclosed in Oil Chemistry, Vol. 43, pp. 31-38 (1994). 1
1 g was dissolved in ether, and 7.1 g of silver carbonate supported on silica gel was obtained.
g and molecular sieve 4A5g were added and reacted at 40 ° C. After distilling off the ether, hydrolyzing with sodium methoxide and further neutralizing with a cation exchange resin, the reaction product was purified by silica gel column chromatography, and linalool oxide-β-D-glucoside 0.51 was purified.
g was obtained. (Yield 15%)
【0016】アミログルコシダーゼによる分解試験 香料配糖体が消化酵素であるアミログルコシダーゼの基
質となるか調べるため香料配糖体のアミログルコシダー
ゼによる分解試験を行い、TLCで生成物を評価した。
ゲラニル−β−D−グルコシド、2−フェニルエチル−
β−D−グルコシドおよびシス−3−ヘキセニル−β−
D−グルコシドについて、10mg/mlのMcIlvaine
緩衝液溶液(pH4.5)200μlを調製し、アミロ
グルコシダーゼ0.56mg/mlのMcIlvaine 緩衝液
溶液(pH4.5)200μlを添加し、55℃で静置
した。6時間後、TLCにより生成物を確認した。試験
結果を表1に示す。Degradation test by amyloglucosidase In order to examine whether or not the flavor glycoside serves as a substrate for the digestive enzyme amyloglucosidase, a degradation test of the flavor glycoside by amyloglucosidase was performed, and the product was evaluated by TLC.
Geranyl-β-D-glucoside, 2-phenylethyl-
β-D-glucoside and cis-3-hexenyl-β-
For D-glucoside, 10 mg / ml of McIlvaine
200 µl of a buffer solution (pH 4.5) was prepared, 200 µl of a McIlvaine buffer solution (pH 4.5) containing 0.56 mg / ml of amyloglucosidase was added, and the mixture was allowed to stand at 55 ° C. After 6 hours, the product was confirmed by TLC. Table 1 shows the test results.
【0017】リパーゼによる分解試験 香料配糖体が消化酵素であるリパーゼの基質となるか調
べるため香料配糖体のリパーゼによる分解試験を行い、
TLCで生成物を評価した。ゲラニル−β−D−グルコ
シド、2−フェニルエチル−β−D−グルコシドおよび
シス−3−へキセニル−β−D−グルコシドについて、
10mg/mlのリン酸ナトリウム緩衝液溶液(pH
7.7)200μlを調製し、リパーゼ21.4μg/
mlのリン酸ナトリウム緩衝液溶液(pH7.7)20
0μlを添加し、37℃で静置した。6時間後、TLC
により生成物を評価した。試験結果を表1に示す。Decomposition test with lipase In order to examine whether the fragrance glycoside serves as a substrate for lipase, which is a digestive enzyme, a lipase decomposition test of the fragrance glycoside was performed.
The product was evaluated by TLC. For geranyl-β-D-glucoside, 2-phenylethyl-β-D-glucoside and cis-3-hexenyl-β-D-glucoside,
10 mg / ml sodium phosphate buffer solution (pH
7.7) Prepare 200 μl and add 21.4 μg /
20 ml of sodium phosphate buffer solution (pH 7.7)
0 μl was added and left at 37 ° C. After 6 hours, TLC
The product was evaluated by Table 1 shows the test results.
【0018】β−グルコシダーゼによる分解試験 香料配糖体が腸内細菌であるβ−グルコシダーゼの基質
となるか調べるため香料配糖体のβ−グルコシダーゼに
よる分解試験を行い、TLCにより生成物を評価すると
ともに、その香料配糖体から香料成分の生成をガスクロ
マトグラフィーを用いて評価した。ゲラニル−β−D−
グルコシド、2−フェニルエチル−β−D−グルコシド
およびシス−3−ヘキセニル−β−D−グルコシドにつ
いて、10mg/mlのクエン酸緩衝液溶液(pH5.
0)5mlを調製し、β−グルコシダーゼを50mg添
加し、37℃で静置した。1時間後、TLC分析し、ま
た、香気成分をエーテルで抽出してガスクロマトグラフ
ィーで分析した。試験結果を表1および2に示す。Degradation Test with β-Glucosidase In order to examine whether the fragrance glycoside serves as a substrate for β-glucosidase which is an intestinal bacterium, a decomposition test of the fragrance glycoside with β-glucosidase is performed, and the product is evaluated by TLC. At the same time, the production of flavor components from the flavor glycoside was evaluated using gas chromatography. Geranyl-β-D-
For glucoside, 2-phenylethyl-β-D-glucoside and cis-3-hexenyl-β-D-glucoside, a 10 mg / ml citrate buffer solution (pH 5.
0) 5 ml was prepared, 50 mg of β-glucosidase was added, and the mixture was allowed to stand at 37 ° C. One hour later, TLC analysis was performed, and aroma components were extracted with ether and analyzed by gas chromatography. The test results are shown in Tables 1 and 2.
【0019】[0019]
【表1】 [Table 1]
【0020】[0020]
【表2】 [Table 2]
【0021】表1に示したとおり、香料配糖体は消化酵
素であるアミログルコシダーゼ、リパーゼにより分解さ
れなかったが、腸内細菌の持つβ−グルコシダーゼによ
り速やかに分解された。また、表2に示したとおり、香
料配糖体からβ−グルコシダーゼにより香料成分が生成
した。As shown in Table 1, the fragrance glycoside was not degraded by the digestive enzymes amyloglucosidase and lipase, but was rapidly degraded by β-glucosidase of the intestinal bacteria. In addition, as shown in Table 2, a flavor component was produced from the flavor glycoside by β-glucosidase.
【0022】腸内細菌による香料配糖体代謝試験 腸内細菌による香料配糖体の代謝試験を行い、香料配糖
体からの香料成分の生成をガスクロマトグラフィーを用
いて評価した。5mlのPYF(Peptone Ye
ast extract Fildes soluti
on)培地に2−フェニルエチル−β−D−グルコシド
を10mM添加した。本液体培地にEGF(Egger
th Gagnon Fildes solutio
n)培地にて培養した各種腸内細菌の菌液0.4%を接
種し、37℃で嫌気培養した。培養2日後にエーテルで
抽出し、ガスクロマトグラフィーで分析した。結果を表
3に示す。Metabolism test of fragrance glycoside by intestinal bacteria Metabolism test of fragrance glycoside by intestinal bacteria was performed, and the production of fragrance components from the fragrance glycoside was evaluated using gas chromatography. 5 ml of PYF (Peptone Ye)
ast extract Fields soluti
on) 10 mM 2-phenylethyl-β-D-glucoside was added to the medium. EGF (Egger)
the Gagnon Fields solution
n) 0.4% of bacterial liquid of various intestinal bacteria cultured in a medium was inoculated and anaerobically cultured at 37 ° C. Two days after the culture, the mixture was extracted with ether and analyzed by gas chromatography. Table 3 shows the results.
【0023】[0023]
【表3】 [Table 3]
【0024】表3に示したとおり、香料配糖体から2−
フェニルエチルアルコールを生成する腸内細菌株は、被
験株6種のうち5種であった。As shown in Table 3, the flavor glycoside was converted to 2-
Intestinal bacterial strains producing phenylethyl alcohol were 5 of the 6 tested strains.
【0025】[0025]
【発明の実施の形態】以下に実施例を挙げて、本発明を
さらに詳細に説明するが、本発明の範囲はこれらの実施
例に限定されるものではない。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described in more detail with reference to the following examples, but the scope of the present invention is not limited to these examples.
【0026】実施例1〜3および比較例 表4に示す処方によりキャンディーを作製した。各キャ
ンディーはその製造に慣用的に用いられる常法に従って
作製された。Examples 1 to 3 and Comparative Example Candies were prepared according to the formulations shown in Table 4. Each candy was made according to the conventional method commonly used for its production.
【0027】[0027]
【表4】 [Table 4]
【0028】官能評価試験 本発明の糞便用芳香消臭組成物についてその芳香消臭作
用および風味を評価するため、成人男女各10名計20
名(25〜56歳)をパネラーとして官能試験を行っ
た。パネラーに1週間のうち3日間(1日当たり6g)
の喫食期間において、実施例1〜3および比較例の組成
物をそれぞれ喫食させ(計4週間)るとともに、風味と
排便の臭いに関して表5に示した評価基準に照らした判
定をさせ、風味および糞便臭に対する芳香消臭作用を点
数評価した。その結果を表6に示す。Sensory Evaluation Test In order to evaluate the aroma deodorizing effect and flavor of the stool aroma deodorizing composition of the present invention, a total of 20 adult males and females were evaluated.
A sensory test was conducted using the name (25-56 years old) as a panelist. 3 days a week to panelists (6g per day)
In the eating period, the compositions of Examples 1 to 3 and Comparative Example were each eaten (for a total of 4 weeks), and the flavor and the smell of defecation were judged according to the evaluation criteria shown in Table 5, and the flavor and The aroma deodorizing effect on fecal odor was scored. Table 6 shows the results.
【0029】[0029]
【表5】 [Table 5]
【0030】[0030]
【表6】 [Table 6]
【0031】表6に示したとおり、実施例1〜3の評価
は風味に関しては比較例とほとんど差がなかったが、実
施例1〜3が便に芳香を発現させることが確認され、さ
らに消臭作用をもつことがわかった。As shown in Table 6, the evaluations of Examples 1 to 3 were almost the same as those of the Comparative Example in terms of flavor, but it was confirmed that Examples 1 to 3 developed scent in stool, It was found to have an odor effect.
【0032】実施例4 以下に示す処方によりキャンディーを作製した。 グラニュー糖 45部 水飴(D.E.42) 50部 水 20部 緑茶抽出物(消臭剤) 3部 リナロールオキシド−β−D−グルコシド 3部 香料 1部Example 4 A candy was prepared according to the following recipe. Granulated sugar 45 parts Water syrup (DE.42) 50 parts Water 20 parts Green tea extract (deodorant) 3 parts Linalool oxide-β-D-glucoside 3 parts Flavor 1 part
【0033】実施例5 以下に示す処方により慣用的に用いられる常法に従って
チューインガムを作製した。 ガムベース 20部 砂糖 56部 水飴 13部 ブドウ糖 10部 シス−3−ヘキセニル−β−D−グルコシド 5部 軟化剤 1部 香料 0.5部Example 5 A chewing gum was prepared according to the following formulation according to a commonly used conventional method. Gum base 20 parts sugar 56 parts starch syrup 13 parts glucose 10 parts cis-3-hexenyl-β-D-glucoside 5 parts softener 1 part flavor 0.5 part
【0034】実施例6 以下に示す処方によりチューインガムを作製した。 ガムベース 20部 砂糖 56部 水飴 13部 ブドウ糖 10部 2−フェニルエチル−β−D−グルコシド 5部 緑茶抽出物(消臭剤) 1部 軟化剤 1部 香料 0.5部Example 6 A chewing gum was prepared according to the following formulation. Gum base 20 parts sugar 56 parts starch syrup 13 parts glucose 10 parts 2-phenylethyl-β-D-glucoside 5 parts green tea extract (deodorant) 1 part softener 1 part flavor 0.5 part
【0035】実施例7 以下に示す処方により慣用的に用いられる常法に従って
チョコレートを作製した。 カカオビター 20部 カカオバター 17部 砂糖 43部 全脂粉乳 20部 ゲラニル−β−D−グルコシド 1部 香料 0.2部Example 7 Chocolate was prepared according to the following recipe according to a commonly used conventional method. Cocoa bitter 20 parts Cocoa butter 17 parts Sugar 43 parts Whole milk powder 20 parts Geranyl-β-D-glucoside 1 part Fragrance 0.2 part
【0036】実施例8 以下に示す処方により慣用的に用いられる常法に従って
錠剤を作製した。 乳糖 100部 馬鈴薯でんぷん 100部 2−フェニルエチル−β−D−グルコシド 60部Example 8 Tablets were prepared according to the following formulation according to a commonly used conventional method. Lactose 100 parts Potato starch 100 parts 2-phenylethyl-β-D-glucoside 60 parts
【0037】実施例9 以下に示す処方によって慣用的に用いられる常法に従っ
てビスケットを作製した。 薄力粉 100部 ショートニング 30部 粉糖 32部 水飴(D.E.42) 5部 脱脂粉乳 1.8部 食塩 1.1部 市販の2−フェニルエチル−β−D−ガラクトシド 1部 (SIGMA社製) 膨化剤 0.45部Example 9 A biscuit was prepared according to the following recipe according to a commonly used conventional method. Soft flour 100 parts Shortening 30 parts Powdered sugar 32 parts Ginger syrup (DE.42) 5 parts Skim milk powder 1.8 parts Salt 1.1 parts Commercial 2-phenylethyl-β-D-galactoside 1 part (manufactured by SIGMA) 0.45 parts leavening agent
【0038】[0038]
【発明の効果】本発明の香料配糖体は、経口摂取された
場合、唾液を含む消化酵素により分解されがたいが、腸
内細菌により分解されることによって香料成分を分離生
成し、それは排便時に便とともに排出される。その香料
成分は、糞便にフローラルな香りやグリーンノート等ヒ
トに好ましい芳香を与え、かつ、糞便の悪臭をマスキン
グし中和すると認められる。The perfume glycoside of the present invention, when ingested orally, is difficult to be decomposed by digestive enzymes including saliva, but is decomposed by intestinal bacteria to separate and produce perfume components. Sometimes discharged with stool. It is recognized that the fragrance component imparts a preferable fragrance to humans, such as a floral scent or green notes, and masks and neutralizes the odor of feces.
【0039】本発明組成物によれば、香料成分が香料配
糖体として存在するため、従来の消臭剤との併用におい
ても、その従来の消臭剤による芳香の消失は起こらず、
かえって消臭作用が相加または相乗的に増加することも
認められた。According to the composition of the present invention, since the fragrance component exists as a fragrance glycoside, even when used in combination with a conventional deodorant, the fragrance does not disappear due to the conventional deodorant.
On the contrary, it was also recognized that the deodorizing effect increased additively or synergistically.
Claims (3)
料配糖体を有効成分として含有することを特徴とする糞
便用芳香消臭組成物。1. A fecal aroma deodorant composition comprising, as an active ingredient, a perfume glycoside in which the bond between a perfume compound and sugar is a β bond.
β結合である香料配糖体を有効成分として含有すること
を特徴とする糞便用芳香消臭組成物。2. A fecal aroma deodorant composition comprising, as an active ingredient, a perfume glycoside in which the bond between a fragrance compound having a hydroxyl group and sugar is a β bond.
が約0.01〜約30重量%の範囲であることを特徴と
する請求項1または2記載の糞便用芳香消臭組成物。3. The stool deodorant composition according to claim 1, wherein the concentration of the fragrance glycoside in the composition is in the range of about 0.01 to about 30% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8204132A JPH1028724A (en) | 1996-07-16 | 1996-07-16 | Fragrant deodorizing composition for feces |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8204132A JPH1028724A (en) | 1996-07-16 | 1996-07-16 | Fragrant deodorizing composition for feces |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH1028724A true JPH1028724A (en) | 1998-02-03 |
Family
ID=16485373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8204132A Pending JPH1028724A (en) | 1996-07-16 | 1996-07-16 | Fragrant deodorizing composition for feces |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH1028724A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000064453A1 (en) * | 1999-04-23 | 2000-11-02 | Meiji Seika Kaisha, Ltd. | Intestinal fermentation sulfide deodorizers |
| US7234648B2 (en) | 2003-10-31 | 2007-06-26 | The Procter And Gamble Company | Volatile substance-controlling composition |
-
1996
- 1996-07-16 JP JP8204132A patent/JPH1028724A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000064453A1 (en) * | 1999-04-23 | 2000-11-02 | Meiji Seika Kaisha, Ltd. | Intestinal fermentation sulfide deodorizers |
| US7234648B2 (en) | 2003-10-31 | 2007-06-26 | The Procter And Gamble Company | Volatile substance-controlling composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2346594T3 (en) | ANTIMICROBIAL AROMATIZING COMPOSITION. | |
| KR101285264B1 (en) | Use of trans-pellitorin as an aroma substance | |
| US20080220140A1 (en) | Use of propenylphenyl glycosides for enhancing sweet sensory impressions | |
| KR101290608B1 (en) | Noncarious material and anticarious agent containing rare sugar | |
| KR0181013B1 (en) | Cosmetic composition containing crystalline 2-o-alpha-di-glucopyranosyl-L-ascorbic acid | |
| US8992892B2 (en) | Use of 1-(2,4-dihydroxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyl)-propan-1-one | |
| JPS646752B2 (en) | ||
| KR20190003473A (en) | Use of 3- (3-hydroxy-4-methoxy-phenyl) -l- (2,4,6-trihydroxy-phenyl) -propan-1- | |
| CN107249356A (en) | Method for the steviol glycoside compound for being orally ingested or using, composition and for strengthening steviol glycoside solubility | |
| JP2016537317A (en) | Mixture of composition | |
| EP4103575B1 (en) | Process for the preparation of allulose in crystal form | |
| JP4422819B2 (en) | Deodorant, food and drink containing the same, composition for oral cavity and toiletry product | |
| CN115427421A (en) | 3' -ketoside compounds with slow release of volatile alcohols | |
| JP5447392B2 (en) | Chewing gum composition | |
| Borrego et al. | Neohesperidin dihydrochalcone | |
| JP2021155374A (en) | Intestinal equol-producing bacteria-increasing agent, equol production-promoting agent, and blood equol concentration-increasing agent | |
| EP3864966A1 (en) | Oral compositions comprising allulose crystals | |
| JPH0342080B2 (en) | ||
| JPH0692829A (en) | Oral composition | |
| JPH09191832A (en) | Chewing gum | |
| JPH0368664B2 (en) | ||
| JPH0336518B2 (en) | ||
| JPS5856628B2 (en) | Manufacturing method for food and drinks, etc. | |
| JP2000178158A (en) | Oral cavity agent | |
| JPH03164193A (en) | Partially decomposed starch containing alpha-glycosyl-glycyrrhizin, its production and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20041124 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050517 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050927 |